Johnson & Johnson beat Wall Street’s expectations for first-quarter profit and revenue on Tuesday, as strong growth in the U.S. offset weakness internationally. The medical-technology and drug company raised its outlook for full-year sales but kept its profit guidance intact.

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year.

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall Street